Newron Pharmaceuticals S.p.A.
SIX:NWRN.SW
8.2 (CHF) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) CHF.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 9.057 | 6.094 | 5.762 | 5.258 | 7.038 | 4.025 | 13.428 | 6.726 | 2.38 | 1.557 | 3.539 | 8.924 | 0.28 | 0.806 | 2.542 | 3.933 | 4.024 | 1.191 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 0.295 | 1.425 | 1.372 | 0 | 2.634 | 1.262 | 0.477 | 0.269 | 0.028 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 9.057 | 6.094 | 5.762 | 4.963 | 5.613 | 2.653 | 13.428 | 4.092 | 1.118 | 1.08 | 3.27 | 8.896 | 0.28 | 0.806 | 2.542 | 3.933 | 4.024 | 1.191 | 0 |
| Gross Profit Ratio
| 1 | 1 | 1 | 0.944 | 0.798 | 0.659 | 1 | 0.608 | 0.47 | 0.694 | 0.924 | 0.997 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Reseach & Development Expenses
| 13.152 | 12.049 | 10.759 | 16.33 | 22.459 | 15.819 | 13.383 | 19.238 | 16.572 | 14.467 | 4.537 | 3.534 | 3.822 | 15.922 | 18.544 | 12.881 | 8.197 | 11.488 | 10.599 |
| General & Administrative Expenses
| 3.982 | 7.15 | 7.241 | 8.06 | 9.776 | 8.441 | 8.076 | 8.824 | 8.126 | 6.57 | 3.791 | 4.151 | 6.898 | 6.451 | 8.468 | 9.256 | 9.447 | 6.619 | 4.544 |
| Selling & Marketing Expenses
| 0.08 | 0.081 | 0.038 | 0.331 | 0.634 | 0.406 | 0.708 | 0.513 | 0.053 | 0.053 | 0.015 | 0.062 | 0.051 | 0.073 | 0.086 | 0.115 | 0.131 | 0 | 0 |
| SG&A
| 4.062 | 7.391 | 7.394 | 8.471 | 10.497 | 9.168 | 9.499 | 10.013 | 8.579 | 6.948 | 3.806 | 4.213 | 6.949 | 6.524 | 8.554 | 9.371 | 9.578 | 6.619 | 4.544 |
| Other Expenses
| 3.472 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.972 | 3.874 | -0.01 | 0 | 0 | 0 | 0 | -0.164 | -0.067 |
| Operating Expenses
| 20.686 | 19.675 | 17.782 | 22.698 | 26.819 | 19.12 | 18.848 | 22.036 | 27.486 | 12.387 | 11.315 | 11.621 | 6.762 | 22.446 | 27.098 | 22.252 | 17.775 | 17.943 | 15.076 |
| Operating Income
| -11.629 | -13.302 | -12.357 | -18.066 | -20.899 | -14.978 | -4.096 | -15.325 | -17.675 | -9.09 | -7.776 | -2.697 | -6.482 | -21.64 | -24.556 | -18.319 | -13.681 | -16.752 | -15.076 |
| Operating Income Ratio
| -1.284 | -2.183 | -2.145 | -3.436 | -2.969 | -3.721 | -0.305 | -2.278 | -7.426 | -5.838 | -2.197 | -0.302 | -23.15 | -26.849 | -9.66 | -4.658 | -3.4 | -14.065 | 0 |
| Total Other Income Expenses Net
| -4.571 | -4.17 | -2.527 | -1.552 | 0.737 | -0.041 | -1.205 | 0.121 | -7.308 | -1.633 | 0.063 | 0.228 | 0.045 | -0.033 | 0.205 | 1.963 | 2.593 | 0.351 | 0.157 |
| Income Before Tax
| -16.2 | -17.472 | -14.884 | -19.618 | -20.162 | -15.019 | -5.301 | -15.204 | -24.983 | -10.723 | -7.713 | -2.497 | -6.437 | -21.673 | -24.351 | -16.356 | -11.088 | -16.401 | -14.919 |
| Income Before Tax Ratio
| -1.789 | -2.867 | -2.583 | -3.731 | -2.865 | -3.731 | -0.395 | -2.26 | -10.497 | -6.887 | -2.179 | -0.28 | -22.989 | -26.89 | -9.579 | -4.159 | -2.755 | -13.771 | 0 |
| Income Tax Expense
| 0.024 | 0.021 | 0.017 | 1.38 | 0.045 | 0.016 | 0.019 | 0.033 | 2.167 | 0.628 | -0.615 | -0.122 | 0.008 | -1.128 | -0.87 | 0.008 | 0.001 | -0.351 | -0.157 |
| Net Income
| -16.224 | -17.493 | -14.901 | -20.998 | -20.207 | -15.035 | -5.282 | -15.237 | -22.816 | -10.095 | -7.098 | -2.375 | -6.445 | -20.545 | -23.481 | -16.364 | -11.089 | -16.401 | -14.919 |
| Net Income Ratio
| -1.791 | -2.871 | -2.586 | -3.994 | -2.871 | -3.735 | -0.393 | -2.265 | -9.587 | -6.484 | -2.006 | -0.266 | -23.018 | -25.49 | -9.237 | -4.161 | -2.756 | -13.771 | 0 |
| EPS
| -0.91 | -0.98 | -0.84 | -1.18 | -1.13 | -0.84 | -0.32 | -1.04 | -1.66 | -0.8 | -0.62 | -0.29 | -0.89 | -3.11 | -3.86 | -2.74 | -1.9 | -4.33 | -5.29 |
| EPS Diluted
| -0.91 | -0.98 | -0.84 | -1.18 | -1.13 | -0.84 | -0.32 | -1.04 | -1.66 | -0.8 | -0.62 | -0.29 | -0.89 | -3.11 | -3.86 | -2.74 | -1.9 | -4.33 | -5.29 |
| EBITDA
| -11.831 | -13.265 | -12.31 | -17.994 | -20.847 | -14.786 | -4.048 | -15.292 | -17.604 | -9.057 | -7.737 | -2.418 | -6.332 | -21.491 | -24.032 | -18.048 | -13.538 | -16.752 | -15.076 |
| EBITDA Ratio
| -1.306 | -2.177 | -2.136 | -3.422 | -2.962 | -3.674 | -0.301 | -2.274 | -7.397 | -5.817 | -2.186 | -0.271 | -22.614 | -26.664 | -9.454 | -4.589 | -3.364 | -14.065 | 0 |